Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas

Acta Neuropathologica

Volumn 107, Issue 5, 2004, Pages 443-451

  Kotoula, V ^a   Barbanis, S ^a   Nikolakaki, E ^b   Koufoyannis, D ^a   Papadimitriou, C S ^a   Karkavelas, G ^a,c  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c NONE   (Greece)

Author keywords

Astrocytic gliomas; Human telomerase catalytic subunit; In situ hybridization; Relative expression; Splice variant profile

Indexed keywords

MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ADOLESCENT; ADULT; AGED; ANALYTICAL ERROR; ARTICLE; ASTROCYTIC GLIOMA; CANCER GRADING; CARCINOGENESIS; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ENZYME SUBUNIT; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

EID: 2342435109     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-004-0832-4     Document Type: Article

References (37)

1. Bieche I, Nogues C, Paradis V, Olivi M, Bedossa P, Lidereau R, Vidaud M (2000) Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 6:452-459
2. Cabuy E, Ridder L de (2001) Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo. Virchows Arch 439:176-184
3. Cerezo A, Kalthoff H, Schuermann M, Schaefer B, Boukamp P (2002) Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT. J Cell Sci 115:1305-1312
4. Chong EY, Lam PY, Poon WS, Ng HK (1998) Telomerase expression in gliomas including the nonastrocytic tumors. Hum Pathol 29:599-603
5. Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, Reddel RR (2000) The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2: 426-432
6. De Kok JB, Schalken JA, Aalders TW, Ruers TJ, Willems HL, Swinkels DW (2000) Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas. Int J Cancer 87:217-220
7. Ducrest AL, Amacker M, Mathieu YD, Cuthbert AP, Trott DA, Newbold RF, Nabholz M, Lingner J (2001) Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Cancer Res 61:7594-7602
8. Falchetti ML, Pallini R, Larocca LM, Verna R, D'Ambrosio E (1999) Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas. J Clin Pathol 52:234-236
9. Falchetti ML, Pallini R, D'Ambrosio E, Pierconti F, Martini M, Cimino-Reale G, Verna R, Maira G, Larocca LM (2000) In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme. Int J Cancer 88:895-901
10. Gentle A, Anastasopoulos F, McBrien NA (2001) High-resolution semi-quantitative real-time PCR without the use of a standard curve. Biotechniques 31:502-508
11. Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB, DePinho RA (1999) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18:1219-1226
12. Harada K, Kurisu K, Tahara H, Tahara E, Ide T, Tahara E (2000) Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker. J Neurosurg 93:618-625
13. Huang F, Kanno H, Yamamoto I, Lin Y, Kubota Y (1999) Correlation of clinical features and telomerase activity in human gliomas. J Neurooncol 43:137-142
14. Jong HS, Park YI, Kim S, Sohn JH, Kang SH, Song SH, Bang YJ, Kim NK (1999) Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer 86:559-565
15. Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA (1997) Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6:2011-2019
16. Kleinschmidt-DeMasters BK, Hashizumi TL, Sze CI, Lillehei KO, Shroyer AL, Shroyer KR (1998) Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling. Clin Pathol 51:284-293
17. Kleinschmidt-Demasters BK, Evans LC, Bobak JB, Lopez-Uribe D, Hopper D, Shroyer AL, Shroyer KR (2000) Quantitative telomerase expression in glioblastomas shows regional variation and down-regulation with therapy but no correlation with patient outcome. Hum Pathol 31:905-913
18. Kotoula V, Hytiroglou P, Pyrpasopoulou A, Saxena R, Thung SN, Papadimitriou CS (2002) Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers. Liver 22:57-69
19. Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P (2003) Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma. Am J Pathol 162:1019-1026
20. Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Shay JW (1995) Telomerase activity in human brain tumours. Lancet 346:1267-1268
21. Le S, Zhu JJ, Anthony DC, Greider CW, Black PM (1998) Telomerase activity in human gliomas. Neurosurgery 42:1120-1124
22. Li H, Zhao L, Yang Z, Funder JW, Liu JP (1998) Telomerase is controlled by protein kinase Calpha in human breast cancer cells. J Biol Chem 273:33436-33442
23. Liu K, Schoonmaker MM, Levine BL, June CH, Hodes RJ, Weng NP (1999) Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci USA 96:5147-5152
24. Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM, Johansson J, Skinner KA, Chandrasoma P, DeMeester SR, Bremner CG, Tsai PI, Danenberg PV (2000) Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg 4:135-142
25. Pallini R, Pierconti F, Falchetti ML, D'Arcangelo D, Fernandez E, Maira G, D'Ambrosio E, Larocca LM (2001) Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells. J Neurosurg 94: 961-971
26. Renaud S, Bosman FT, Benhattar I (2003) Implication of the exon region in the regulation of the human telomerase reverse transcriptase gene promoter. Biochem Biophys Res Commun 300:47-54
27. Sonoda Y, Ozawa T, Hirose Y, Aldape KD, McMahon M, Berger MS, Pieper RO (2001) Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res 61:4956-4960
28. Sugita Y, Nakashima A, Kato S, Sakata K, Morimatsu M, Shigemori M (2000) Telomerase activity in gliomas with the use of non-radioisotopic and semi-quantitative procedure for terminal repeat amplification protocol. Oncol Rep 7:1087-1092
29. Sumida T, Hamakawa H, Sogawa K, Sugita A, Tanioka H, Ueda N (1999) Telomerase components as a diagnostic tool in human oral lesions. Int J Cancer 80:1-4
30. Tchirkov A, Rolhion C, Kemeny JL, Irthum B, Puget S, Khalil T, Chinot O, Kwiatkowski F, Perissel B, Vago P, Verrelle P (2003) Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomas. Br J Cancer 88:516-520
31. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR (1998) Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58:4168-4172
32. Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC, Hoffman AR (2000) Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer 85:330-335
33. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR (2001) Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int J Cancer 91:644-649
34. Wick M, Zubov D, Hagen G (1999) Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232:97-106
35. Yi X, White DM, Aisner DL, Baur JA, Wright WE, Shay JW (2000) An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2:433-440
36. Yi X, Shay JW, Wright WE (2001) Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 29:4818-4825
37. Zaffaroni N, Delia Porta C, Villa R, Botti C, Buglioni S, Mottolese M, Grazia Daidone M (2002) Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity. J Pathol 198:37-46